Background
==========

Malignant soft tissue tumors account for \< 1% of malignant tumors in adults \[[@B1]\], Leiomyosarcomas make up only \< 5% of these rare soft tissue tumors \[[@B2]\].

Intraabdominal, retroperitoneal, cutaneous, subcutaneous and vascular growth patterns can be distinguished. Vascular leiomyosarcoma arises from major blood vessels and originates directly from the muscular wall of these vessels.

Up to 75% \[[@B3]\] arise from the retroperitoneal course of the inferior vena cava \[[@B4]\]. As with other soft tissue sarcomas clinical presentation may be delayed due to their deep origin. Presentation include palpable masses or intraluminal obstruction with signs of venous stases, thrombosis or embolism. Extracaval venous branches are a particularly rare source of vascular leiomyosarcomas and most frequently involve venous branches of the lower extremity \[[@B4]\]. Due to its rare incidence and the unusual clinical course the diagnosis and special treatment requirements are often challenging for the multidisciplinary team. We reviewed our experience with vascular leiomysarcomas with special reference to the clinical course and outcome. Differential diagnosis, clinical and pathological criteria will be discussed.

Methods and Materials
=====================

A search of our prospectively updated soft tissue tumor database revealed 182 patients diagnosed with a leiomyosarcoma from 2000 to 2009 at the BG University Hospital Bergmannsheil. Twelve of these tumors had an intravascular origin. Patients\' notes were evaluated and patients and their physicians were contacted for details regarding the clinical course, follow-up and outcome. Follow-up imagine was obtained for all patients and included chest X-ray or CT scan, abdominal ultrasound, CT or MRI scan of the tumor site.

Local recurrence was defined as tumor relapse at the primary tumor resection site and metastatic disease was defined as tumor growth at any other site. Results are presented as means and standard deviation. Three year survival was calculated using the Kaplan - Meier method.

Due to the small number of patients we refrained from further statistical analysis.

Histology
---------

Histological slides of the primary tumor were (re-) assessed by a pathologist\* with expertise in soft tissue pathology from the Institute of Pathology, BG University Hospital Bergmannsheil. In all cases additional immunohistochemistry was performed to confirm the diagnosis. Second expert opinions from another pathologists were obtained in two cases. The primary diagnosis of an intravascular leiomyosarcoma of our institute was confirmed in both cases.

\*The histopathological assessment by Prof. C.Kuhnen was carried out predominantly during his time at the Institute of Pathology, BG-University-Hospital \"Bergmannsheil\", Ruhr-University, Bochum, Germany

Results
=======

1613 patients with a malignant soft tissue tumor (MSTT) were treated at our institute between 2000 and 2009. 182 tumors (11% of all MSTT) were diagnosed as leiomyosarcoma. Twelve of these tumors were of intravascular origin. Intravascular leiomyosarcoma accounted for 0.7% of all MSTT or 6% of all leiomyosarcomata. The mean age at the time of diagnosis was 59 years (± 10.7). Nine patients were females and three were males. The mean follow-up time from the time of definite surgery of the primary tumor was 38 months (± 30.6). The three year survival was 57%. Due to the insidious onset of the disease and late clinical symptoms the time between onset of tumor growth and the definite diagnosis could not be assessed.

The site of tumor growth was the lower extremity in 67%, the upper extremity in 25% and the vena cava in 8%.

In 50% the disease initially presented with signs of venous stasis. Deep venous thrombosis (n = 1), thrombophlebitis of the long saphenous vein (n = 2) and acute pulmonary embolism (n = 1) occurred as initial symptoms of the malignancy.

67% of the tumors were subfascial and 25% epifascial. In 33% the tumor originated from the femoral vein. Mean tumor size was 7.4 cm in largest diameter (± 3.0).

17% of the tumors were T~I~and 83% were T~II~.

At primary diagnosis no metastatic disease was detected in any patient.

According to the Coindre classification of tumor grading for soft tissue tumors, the tumors were subdivided in high grade (42%), intermediate (42%) and low grade (16%). (Table [1](#T1){ref-type="table"})

###### 

Data of the patient collective and clinical course of the tumor disease.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Age at the time of diag.   Localisation                   Affected vessel                          Size in cm       TNM             Comments                                                                                                  Thrombembolic event                                         Status
  --------- -------------------------- ------------------------------ ---------------------------------------- ---------------- --------------- --------------------------------------------------------------------------------------------------------- ----------------------------------------------------------- --------
  **1**     66                         right upper extremity,\        internal Jugular vein/sub-clavian vein   7.6 × 8 × 3.3    T2 N0 M0\       second expert opinion                                                                                     n                                                           DOD
                                       supra-clavicula region                                                                   G2                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **2**     74                         left thigh                     femoral vein                             \-               \--             no diagnosis before primary surgery                                                                       n                                                           DOD

                                                                                                                                                                                                                                                                                                                      

  **3**     77                         Left upper extremity, wrist    accompaniing ulna vein                   2.7×1.7×1.2      T1 N0 M0\       initial surgery for a suspected wrist ganglion revealed the diagnosis of a intravascular leiomyosarcoma   n                                                           alive
                                                                                                                                G1                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **4**     52                         right thigh                    femoral vein                             6.4 × 7 × 9      T2 N0 M0\       palpable tumor 4 month before diagnosis                                                                   n                                                           DOD
                                                                                                                                G3                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **5**     55                         left dorsum of the upper arm   subcutaneous Vein                        7.8 × 4.5 × 5    T2 N0 M0\       palpable tumor 2 month before diagnosis                                                                   n                                                           alive
                                                                                                                                G3                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **6**     64                         right thigh                    subcutaineous vein                       2.5 × 2 × 1      T1 N0 M0\       palpable tumor 3-4 month before diagnosis; external primary tumor enucliation\                            n                                                           alive
                                                                                                                                G2              second expert opinion                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                      

  **7**     41                         retro-peritoneum               inferior vena cava                       8.8 × 6 × 5      T2 N0 M0\       primary histology Pathol. BG-Uni. Bergmannsheil Bochum; Second expert opinion Oncological resection\      n                                                           alive
                                                                                                                                G1              Dep. Visceral Surg. Uni Bochum                                                                                                                                        

                                                                                                                                                                                                                                                                                                                      

  **8**     56                         right thigh                    external iliac vein, femoral vein        10.1 × 7.5 × 5   T2 N0 M0\       3 tumor free lymph nodes in primary histology\                                                            deep vein throm-bosis                                       alive
                                                                                                                                G2              Oncological resection Dep. Visceral Surg. Uni Bochum                                                                                                                  

                                                                                                                                                                                                                                                                                                                      

  **9**     61                         left thigh                     femoral vein                             2.3 × 2 × 6      T2 N0 M0\       \-                                                                                                        n                                                           DOD
                                                                                                                                G2                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **10**    59                         left thigh                     femoral vein                             9.6 × 6 × 4      T2 N0 M0\       Histology was reassessed after transferral due to a tumor relapse                                         pulmonary embo-lism                                         alive
                                                                                                                                G3                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **11**    44                         left thigh                     great saphenous vein                     12 × 4 × 3.6     T2 N0 M1\       palpable small tumor, suspected to be a lipoma two years prior to diagnosis                               thrombophlebitis of the saphenous vein                      alive
                                                                                                                                (lung,\                                                                                                                                                                               
                                                                                                                                liver)\                                                                                                                                                                               
                                                                                                                                G3                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                      

  **12**    56                         left lower leg                 great sahpenous vein                     5 × 4 × 1        T2N0\           crossectomy                                                                                               thrombophlebitis preop., paget shrotter syn-drome postop.   alive
                                                                                                                                M1 (pulmo) G3                                                                                                                                                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Primary diagnosis was provided by incisional biopsy in two cases and punch biopsy in a further two cases prior to surgical ablation. Five patients were resected with microscopically positive margins at other institutes and were referred to our center for definitive ablation. One patient presented with the clinical symptoms of a wrist ganglion. After the initial tumor resection the histological assessment revealed a vascular leiomyosarcoma. The definite surgical intervention required a resection of the ulnar artery and accompanying vena comitantes. Two patients were transferred to our center after tumor relapse. One of them initially underwent vascular bypass surgery for a suspected malignant fibrous histiocytoma (N^[O.]{.ul}^ 2). The initial incorrect pathological assessment was benign. Tumor relapse led to the diagnosis of aleiomysarcoma. At that time the tumor surrounded the vascular prosthesis and hip implant. Amputation was discussed but refused by the patient. Palliative radiation therapy was initiated and the patient died five months later. In the other patient (N^[O.]{.ul}^ 12) during stripping of the long saphenous vein a tumor mass was encountered and the surgical specimen was sent for histology which demonstrated a leiomyosarcoma. The tumor was resected with positive margins. Despite adjuvant radiation therapy the tumor relapsed. The patient was then admitted to an oncology department where he received adjuvant chemotherapy before being transferred to our center for intervention. Surgery with curative intent required an extended hip amputation. At present there is no evidence of metastatic disease after 14 months.

Three patients had femoral vessel resection and a subsequent arterial bypass.

Patient N^[O.]{.ul}^ 7 required partial resection of the vessel wall of the inferior vena cava. In N^[O.]{.ul}^ 11&12 the tumor bearing segment of the long saphenous vein was resected. The ulnar artery and vein were resected in one patient.

Six patients received adjuvant radiation therapy of the primary tumor bed with a dose of 60 - 72 Gy. Three (N^[O.]{.ul}^ 2,4&9) of these patients died of the disease, one of them (N^[O.]{.ul}^ 2) received radiation therapy with palliative intention and one (N^[O.]{.ul}^ 4) had microscopically positive resection margins after surgical ablation.

Six patients (N^[O.]{.ul}^1;2;,4;9;11 & 12) developed pulmonary metastasis, one patient also suffered from bone metastasis (N^[O.]{.ul}^9), another one (N^[O.]{.ul}^11) had additional liver metastasis. Five of these patients (N^[O.]{.ul}^1;2;9;11 & 12) also developed recurrent disease. In further two patients (N^[O.]{.ul}^1;2) pulmonary metastasis was suspected approximately 6 (N^[O.]{.ul}^1) and 4 (N^[O.]{.ul}^2) months after the definite operation but according to the patients\' wishes no tests were done to confirm the metastatic disease. All but two (N^[O.]{.ul}^11 & 12) patients with metastatic disease died (N^[O.]{.ul}^1 eighteen months N^[O.]{.ul}^2 six months N^[O]{.ul}^4 ten months and N^[O]{.ul}^9 twenty eight months after the final diagnosis was made). One patient received neoadjuvant chemotherapy (N^[O.]{.ul}^9).

Five of these patients sought palliative chemotherapy (N^[O.]{.ul}^ 1, 4,10,11 & 12). Table [2](#T2){ref-type="table"}

###### 

Follow up data of the treatment related course

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  N^O^.    Age/sex   Follow up period in month   Untreated tumor growth   Definite proce-dure   Adjuvant radiation-therapy   Chemo-therapy   Local recurrence    Meta-stasis   Time to death
  -------- --------- --------------------------- ------------------------ --------------------- ---------------------------- --------------- ------------------- ------------- ---------------
  **1**    66/f      18                          \-                       R0                    \-                           adjuvant        5 months            lung          18 months

                                                                                                                                                                               

  **2**    74/f      15                          2years ?                 R1                    60Gy                         \-              tumor-progression   lung?         15 months

                                                                                                                                                                               

  **3**    77/m      84                          \-                       R0                    \-                           \-              \-                  \-            alive

                                                                                                                                                                               

  **4**    52/f      10                          2 month                  R1                    60Gy                         \-              \-                  lung          10 months

                                                                                                                                                                               

  **5**    55/f      82                          \-                       R0                    60Gy                         adjuvant        45 months           \-            alive

                                                                                                                                                                               

  **6**    64/m      78                          4 month                  R0                    \-                           \-              \-                  \-            alive

                                                                                                                                                                               

  **7**    41/f      64                          \-                       R0                    \-                           \-              \-                  \-            alive

                                                                                                                                                                               

  **8**    56/f      43                          \-                       R0                    60Gy                         \-              \-                  \-            alive

                                                                                                                                                                               

  **9**    61/f      28                          \-                       R0                    60Gy                         \-              25 months           lung/bone     28\
                                                                                                                                                                               months

                                                                                                                                                                               

  **10**   59/m      7                           immediate                R1                    \-                           neo-adjuvant    2 months            \-            alive

                                                                                                                                                                               

  **11**   44/f      14                          2 years                  R0                    \-                           adjuvant        12 months           lung/liver    alive

                                                                                                                                                                               

  **12**   56/f      14                          \-                       R0                    72Gy                         adjuvant        10 months           lung          alive
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Macroscopic appearance
----------------------

In all cases tumor growth in close proximity to vascular structures was present. On resection of the tumor bearing vessels the tumors were found to originate from structures of the vessels walls and to exhibit an intravascular tumor sprout. Figure [1](#F1){ref-type="fig"}

![**Macroscopic appearance of a leiomysarcoma specimen after tumor resection at the wrist**.](1477-7819-8-103-1){#F1}

Microscopic appearance of the tumor
-----------------------------------

Histologically a spindle cell, mesenchymal neoplasm was found in all cases associated with the media of the vessel wall, which was assessed as site of tumor origin. The tumor cells were characteristically forming various fascicles and showed an eosinophilic cytoplasm with cigar shaped nuclei. Figure [2](#F2){ref-type="fig"}

![**Histological appearance of a leiomyosarcoma after resection of a tumor in the subclavicular region**. Notice the \"cigar shaped\" configuration of tumor cell nuclei with nuclear atypia (H&E staining).](1477-7819-8-103-2){#F2}

The neoplasm derived from the media of the vessel wall and disrupted the existing vascular architecture. Immunohistochemically the majority of tumor cells displayed a positive reaction for smooth muscle actin and desmin, confirming smooth muscle differentiation of the tumor. Figure [3](#F3){ref-type="fig"}

![**Intraluminal tumour growth of a Leiomyosarcoma originating from great saphenous vein (GSV) (H&E-staining)**. The subcutaneous adipose tissue is labelled SAT.](1477-7819-8-103-3){#F3}

Discussion
==========

Vascular leiomyosarcomata represent only a small proportion of soft tissue leiomyosarcomata \[[@B4]\]. All publications in the literature are of small clinical series or case reports. 11% of the patients treated for a malignant soft tissue tumor at the BG University Hospital Bergmannsheil presented with the leiomyosarcoma. The vascular leiomyosarcomas accounted for 6% of these tumors \[[@B5],[@B6]\] Svarvar et al. recognised an even sex distribution in his study of 225 patients with all types of leiomyosarcoma \[[@B6]\].

In the current series nine patients with a vascular leiomysarcoma were female and three male. In the series of patients with vascular leiomysarcoma from Berlin et al. 5 were males and 1 female \[[@B7]\], in Abed et al.´s group 9 were female and 7 male \[[@B5]\] and in Dzsinich et al.\'s series 12 were female and 1 male \[[@B8]\].

These tumors mainly originate from the media of venous vessel walls, with rare exceptions in which they derive from the arterial vessel structures \[[@B9]\]. The tumor is encountered in the retroperitoneal course of the inferior vena cava in 75% of all intravascular leiomyosarcomata \[[@B3]\]. The patients in our study are mainly extremity soft tissue tumors.

Venous obstruction and a palpable tumor mass were the most common symptoms. Deep venous thrombosis and even pulmonary embolism may be the initial clinical symptoms and can camouflage the clinical manifestation disease \[[@B10]\].

Leiomyosarcomas arising form smaller vessels are less frequent and may present primarily as nerve compression syndrome \[[@B4]\]. These tumors often protrude through small lumina of adjacent venous branches \[[@B7]\]. One of the patients presented with symptoms of arterial occlusion requiring vascular bypass surgery. Unfortunately in this particular case the delayed diagnosis in conjunction with an incorrect pathological assessment delayed the surgical ablation which permitted tumor progression. At this late time point to the patient refused surgical ablation and instead sought palliative radiation therapy.

Venous branches of the lower extremity as well as the azygos vein have been described as unusual sites of manifestation of intravascular leiomyosarcomata in the current literature \[[@B11],[@B12]\]. Tumors localised in the upper extremity or the head and neck region are rare exemptions with reports in the literature limited to single cases \[[@B3],[@B13]-[@B15]\]. In our intravascular leiomyosarcomas of the extremities there were four patients with a tumor origin of the femoral vein, further two cases of larger subcutaneous vein branches of the thigh, two of the long saphenous vein and most interestingly, three patients where the tumor was found in the upper extremity. Similar to our findings Berlin et al. \[[@B7]\] and Abed et al. \[[@B5]\] described the majority of these vascular leiomyosarcomas as arising from the lower extremity. In the combined studies of Abed et al. \[[@B5]\]and Dzsinich et al. \[[@B8]\] and Berlin et al. only one tumor was found in the upper extremity \[[@B7]\].

It has been indicated that small vein structures are the predominant source of the rare intravascular leiomyosarcomata of the deep somatic soft tissue \[[@B16]\].

The clinical picture may either result form the tumor growth itself or be related to the vascular occlusion manifesting as venous stases or thrombosis. A wide range of differential diagnosis may lead to clinical symptoms of venous stasis in the upper and lower extremity for example lung cancer, lymphomas, post thrombotic syndrome \[[@B17]\]. Intravascular neoplasms result in stasis of the blood flow by intraluminal obstruction \[[@B18],[@B19]\]. CT scans, MRI, and angiograms \[[@B7],[@B20]\] demonstrate filling defects in accordance with the clinical signs of vascular compression are valuable diagnostic measures that will facilitate the operative planning when suspecting an intravascular leiomyosarcoma. Particularly MRI can assist in differentiating intravascular tumor growth from thrombosis. In contrast to the intravascular tumor a thrombus commonly presents with a high signal intensity both in the T1 and T2 weighted images whereas the leiomyosarcoma appears as a homogenous tumor with an intermediate signal intensity on T1 - weighted imaging \[[@B21]\]. Moreover CT and MRI will not in all cases allow for an exact image of the endovascular tumor component \[[@B19]\].

An MRI was obtained in all of the presented patients prior to surgical ablation. Two subcutaneous tumors were ablated without imaging of the tumor prior to transfer to our center. The MRI in these patients was conducted before definitive surgery. A preoperative angiogram even though desirable was performed only in the minority of cases. Tumors of the venous vessel wall may present with an intraluminal growth pattern or may extent from the tunica media and infiltrate the surrounding soft tissue \[[@B13]\]. In thin veins especially extension into the perivascular soft tissue may occur early \[[@B4]\].

As vascular leiomyosarcomata are commonly composed of an intraluminal as well as an extravascular tumor component \[[@B7]\] after biopsy diagnosis of a soft tissue leiomyosarcoma the rare possibility of a primary intravascular tumor growth has to be suspected since it may influence the surgical strategy. Primary intravascular tumor growth may necessitate vascular dissection and resection of the tumor bearing course over a longer distance far from the palpable tumor mass due to intraluminal tumor extension \[[@B7],[@B14]\]. The extravascular component of the sarcomata sometimes requires the resection and reconstruction of the adjacent artery as in 33% of the assessed patients.

In these cases both pre- and postoperative pulmonary microthrombembolism are frequent complications especially for tumors of the pulmonary artery \[[@B22]\]. The lung also is the most common site of distant metastasis \[[@B16]\]. Leiomyosarcomata are malignant tumors of mesenchymal origin with a differention towards smooth muscle morphology. The histological appearance is composed of spindle shaped cells with eosinophilic cytoplasm with muscular striation and cigar shaped rounded nuclei. Immunohistochemical staining for contractile fibers proteins such as actin, desmin as well as h-caldesmon can verify the diagnosis. Standard H&E staining and immunohistochemical staining for smooth muscle markers was performed in all of the cases of this series to confirm the diagnosis.

The differential diagnosis embraces the spectrum of spindle cell shaped neoplasms such as benign and malignant tumors of the nerve sheaths, myofibroblastic tumors (myofibromatosis, fibromatosis, myofibroblastic sarcoma), synovial sarcoma, fibrosarcoma and NOS sarcoma \[[@B23]\].

Intimal sarcoma, malignant mesenchymal tumors of the large arteries which originate from the intimal layer of the vessel wall \[[@B24]\] and the very rare intravascular angiosarcoma belong to the differential diagnosis of malignant intravascular tumors \[[@B25]\].

Surgical ablation with clear margins is the therapy of choice \[[@B5]-[@B7]\].

Vascular leiomyosarcomata are associated with aggressive tumor growth, poorer prognosis and earlier onset of metastatases compared to other soft tissue tumors \[[@B26]\]. The high rate of local recurrence and pulmonary metastases seen in the present study confirm these findings. Adjuvant radiation therapy may aid in local tumor control in the case of incomplete tumor resection or higher tumor grade. Tumor size and localization are of prognostic value \[[@B13]\]. Retroperitoneal leiomyosarcoma has similar out come and prognosis to leiomyosarcoma of the extremities \[[@B27]\].

Intravascular growth is associated with early pulmonary metastasis \[[@B16]\]. The three year survival of 57% in the presented study is consistant with the literature. \[[@B5]-[@B7]\] We recommend to include all patients with leiomyosarcomas in an international database to gain epidemiological data and improve the treatment of these rare tumors.

Conclusion
==========

Leiomyosarcomas rarely arise from blood vessel walls. The clinical presentation is misleading and thrombembolic events may be the first symptoms. Intravascular spread may complicate the surgical resection, rendering it difficult to obtain clear margins. The extravenous tumor component may necessitate resection of the concomitant artery or vein which requires vascular reconstruction. Early hematogenous metastasis and a high rate of local recurrence compromise the prognosis of the disease.
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